|
Post by biotec on Feb 3, 2014 17:24:09 GMT -5
56 days until the AdCom, 71 days until FDA Approval ( Lets all hope) And we are almost back to the 4's for pps! Whats going on here? Boy this one is beating me up everyday.Please let us get some great info, Anything, A partnership would work for me.
Bio
|
|
|
Post by rak5555 on Feb 3, 2014 18:21:36 GMT -5
If it goes under $5 I think I will barf on my PC. I'm afraid that failure to announce a partner in a timely fashion is scaring some investors away. In retrospect, I wish management had never made comments related to partner timing. We did not sign a deal by mid summer, we did not sign a deal before end of 2013, and now we are on our way to not signing a deal prior to pdufa. This is just pointless speculation, but I wonder what the share price might be today if they had never created these partner expectations they have consistently failed to meet.
|
|
|
56 days
Feb 3, 2014 18:44:47 GMT -5
Post by biotec on Feb 3, 2014 18:44:47 GMT -5
Great points RAK, This far in the game I'm starting to think no partnership before pdufa. And with greenhill in the game it might be a buyout post approval. And what spiro and Doc said about the future of technosphere, Mannkind might slit the company in 2. JMO
|
|
|
56 days
Feb 3, 2014 18:59:26 GMT -5
Post by rak5555 on Feb 3, 2014 18:59:26 GMT -5
A few weeks ago when there was a flurry of speculation that MNKD might be selling vs partnering, I speculated that they will essentially do both. A very plausible scenario is one where MNKD sells the rights to Afrezza and simultaneously enters into a long term exclusive manufacturing agreement w/ the buyer. It seems like a win win win. Immediate huge up front cash to finance manufacturing build out, a long term cash flow stream from manufacturing contract, mnkd turns development focus to technosphere licensing deals.
|
|
|
56 days
Feb 3, 2014 19:23:53 GMT -5
Post by biotec on Feb 3, 2014 19:23:53 GMT -5
Thats what I was thinking. But What would that do for the share holders? BTW its Afrezza not Afrezza!!!!
|
|
|
56 days
Feb 3, 2014 21:20:42 GMT -5
Post by liane on Feb 3, 2014 21:20:42 GMT -5
Original name for the drug was Afresa. It was changed due to similarities with an existing drug name. Still see this or variants from time to time. Hopefully soon Afrezza will be a household name!
|
|
|
56 days
Feb 3, 2014 22:00:09 GMT -5
Post by alcc on Feb 3, 2014 22:00:09 GMT -5
I have always believed -- and said so here -- that there will be no partnership until after PDUFA. That's what I would do if I were on the board of the partner: wait. That said, my guess is only as good (or bad) as yours.
|
|
|
Post by thsloppy on Feb 4, 2014 6:51:53 GMT -5
Couldn't agree more with Rak. Management has failed to deliver on...well everything. From "non-dilutive financing", data (yes it met endpoints but Al certainly built up higher expectations), adcom, and the many Partners who we have waiting to sign. What else is management not telling us? I'm a longtime long, believer in the need and the science, but I'm done buying even at these levels. I believe we will see a little runup, but it is this sentiment, and the diluted market cap, holding the share price down.
|
|
|
Post by biotec on Feb 4, 2014 8:48:50 GMT -5
Yep I was just thinking how much the market cap has grown in the last couple years, part of that is the FDA's doing, But most the blame is on the management or the lack of it.How many times have we heard of a partner?
|
|
|
Post by krj00 on Feb 4, 2014 9:48:12 GMT -5
Al seemed pretty matter of fact when he said that Mannkind would file for European approval shortly after submission to FDA. "Something" or "someone" apparently changed his mind. A European partner?
|
|
|
Post by biotec on Feb 5, 2014 15:49:52 GMT -5
Rak, Did you buy a new PC yet?
|
|